Global Protein G, L, and A Resin market was valued at USD 778.90 million in 2025 and is expected to reach USD 1,326.27 million by 2034, registering a CAGR of 7.90% over the forecast horizon. The expansion reflects the growing demand for monoclonal antibodies, the momentum of biopharmaceutical manufacturing, and heightened research investment worldwide.

Protein G, L, And A Resin Market – View in Detailed Research Report

Market Size

North America accounted for USD 202.96 million in 2025, with a projected CAGR of 6.77% from 2025 to 2030. The region’s advanced pharmaceutical ecosystem and robust R&D infrastructure underpin its leading position.

Product Definition

Protein A, Protein G, and Protein L resins are essential affinity media used for antibody purification. These proteins bind specifically to immunoglobulins, facilitating their isolation, immobilization, or detection. Each protein has distinct binding profiles:

• Protein A binds primarily to the Fc region of IgG antibodies from various species.
• Protein G has a broader binding profile, capturing IgG subclasses from multiple sources.
• Protein L binds to the kappa light chains of antibodies, allowing purification of a wider range of immunoglobulins.

These resins play a pivotal function in pharmaceutical manufacturing, research applications, and therapeutic antibody production.

Top 10 Companies in the Protein G, L, and A Resin Market

1️⃣ Cytiva (Danaher)

Headquarters: Boston, USA
Key Offering: Protein A, G, L affinity resins and integrated chromatography systems

Cytiva’s portfolio spans high-capacity resins that satisfy GMP standards, enabling efficient purification of diverse IgG subclasses. The company’s recent launch of Protein G resins with enhanced loading capacity addresses the growing need for biosimilar antibody production.

Sustainability Initiatives: Investment in green chemistry to reduce solvent consumption and waste generation.

• Comprehensive GMP compliance across all product lines
• Robust supply chain resilience through dual sourcing
• Active collaboration with biopharma developers on custom resin solutions

2️⃣ Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Protein A and G resins, chromatographic media, and downstream processing solutions

Merck’s focus on high-throughput purification platforms aligns with the rapid scaling of antibody manufacturing. Its protein A resins feature a broad species coverage, supporting global biopharmaceutical operations.

Sustainability Initiatives: Commitment to reducing carbon footprint across manufacturing facilities.

• Integrated process analytics for real-time monitoring
• Extensive R&D pipeline for next‑generation resins
• Strategic partnerships with contract manufacturing organizations

3️⃣ Purolite Corporation

Headquarters: Waltham, USA
Key Offering: Protein L resins, ion exchange media, and specialty binders

Purolite’s Protein L resins cater to a niche segment of light‑chain‑specific purification, offering a solution for antibodies that do not bind efficiently to Protein A or G.

Sustainability Initiatives: Development of low‑water‑usage resin manufacturing processes.

• Strong presence in academic research labs
• Dedicated support for custom resin development
• Active engagement in global antibody market trends

4️⃣ Thermo Fisher Scientific

Headquarters: Waltham, USA
Key Offering: Protein A and G affinity resins, chromatography systems, and analytical tools

Thermo Fisher’s integrated platform enables end‑to‑end purification, from resin selection to process validation. The company’s emphasis on data‑driven process optimization enhances yield and consistency.

Sustainability Initiatives: Adoption of recyclable resin formats and reduced solvent usage.

• Global distribution network with localized support
• Strong focus on digital process control
• Collaborations with biopharma innovators

5️⃣ Repligen Corporation

Headquarters: Waltham, USA
Key Offering: Protein A and G resins, membrane chromatography, and downstream solutions

Repligen’s membrane chromatography technology offers high flow‑through rates, addressing the demand for rapid antibody purification in early‑stage development.

Sustainability Initiatives: Focus on reducing energy consumption in manufacturing.

• High‑throughput screening capabilities
• Partnerships with academic institutions
• Robust quality assurance protocols

6️⃣ GenScript

Headquarters: New York, USA
Key Offering: Protein L resins, recombinant protein production, and antibody engineering services

GenScript’s Protein L resins are tailored for light‑chain‑specific applications, facilitating the purification of antibodies with atypical kappa light chains.

Sustainability Initiatives: Implementation of renewable energy sources in production facilities.

• Comprehensive contract research services
• Rapid turnaround for custom resin orders
• Active participation in global antibody research consortia

7️⃣ Abcam

Headquarters: Cambridge, UK
Key Offering: Protein A and G resins, antibody validation kits, and research reagents

Abcam’s emphasis on reagent quality supports researchers in obtaining reproducible antibody purification results. The company’s resins are widely used in academic laboratories worldwide.

Sustainability Initiatives: Reduction of single‑use plastics in product packaging.

• Extensive global distribution network
• Strong focus on customer education and support
• Collaborations with leading research institutions

8️⃣ GE Healthcare Life Sciences

Headquarters: Chicago, USA
Key Offering: Protein A and G affinity resins, chromatography columns, and analytical instruments

GE Healthcare’s integration of chromatography hardware with software analytics streamlines process development, appealing to large biopharmaceutical manufacturers seeking operational efficiency.

Sustainability Initiatives: Implementation of waste‑minimization protocols in resin production.

• Robust global service network
• Strong R&D focus on next‑generation resins
• Active engagement with regulatory bodies

9️⃣ Sartorius AG

Headquarters: Göttingen, Germany
Key Offering: Protein A, G, and L resins, bioprocess equipment, and downstream solutions

Sartorius’s portfolio covers a full spectrum of affinity media, supporting end‑to‑end antibody production pipelines. Its emphasis on modular systems allows scalable process design.

Sustainability Initiatives: Investment in energy‑efficient manufacturing lines.

• Global footprint across North America, Europe, and Asia
• Strong partnership with contract manufacturers
• Focus on data‑driven process optimization

🔟 EMD Millipore (Merck KGaA)

Headquarters: Darmstadt, Germany
Key Offering: Protein A and G affinity resins, chromatography media, and analytical services

EMD Millipore’s resins are recognized for their high binding capacity and low non‑specific binding, essential for high‑purity antibody production. The company’s global service network supports large‑scale manufacturing projects.

Sustainability Initiatives: Adoption of circular economy principles in resin manufacturing.

• Comprehensive quality management system
• Strong presence in the biopharma sector
• Collaborations with regulatory agencies

Download FREE Sample Report

Get Full Report

Outlook

The Protein G, L, and A Resin market is positioned to benefit from the continued acceleration of antibody therapeutics and the shift toward personalized medicine. Regions such as Asia‑Pacific and Latin America are expanding their biopharmaceutical capabilities, creating new opportunities for resin suppliers to capture market share.

Future Trends

• Increased adoption of high‑capacity resins that deliver higher loading densities
• Integration of digital analytics for real‑time process monitoring
• Expansion of modular chromatography platforms for flexible scale‑up
• Greater emphasis on sustainability across the resin manufacturing cycle